Literature DB >> 14715831

Features of the metabolic syndrome after childhood craniopharyngioma.

S Srinivasan1, G D Ogle, S P Garnett, J N Briody, J W Lee, C T Cowell.   

Abstract

Obesity and multiple pituitary hormone deficiency are common complications after surgery for childhood craniopharyngioma. We hypothesized that post craniopharyngioma surgery, children are at high risk for the metabolic syndrome, including insulin resistance due to excess weight gain and GH deficiency. This study characterized body composition (anthropometry and dual energy x-ray absorptiometry) and metabolic outcomes in 15 children (10 males and 5 females; age, 12.2 yr; range, 7.2-18.5 yr) after surgical removal of craniopharyngioma. In 9 subjects, outcomes were compared with those of healthy age-, sex-, body mass index-, and pubertal stage-matched controls. Insulin sensitivity was measured by 40-min iv glucose tolerance test. Seventy-three percent of subjects were overweight or obese. Sixty-six percent had normal growth velocity without GH treatment. Subjects had increased abdominal adiposity (P = 0.008) compared with controls. However, there was no significant difference in total body fat. Subjects had higher fasting triglycerides (P = 0.02) and lower high density lipoprotein cholesterol to total cholesterol ratio (P = 0.015). Insulin sensitivity was equally reduced for subjects and controls (P = 0.86). After craniopharyngioma removal, patients had more features of the metabolic syndrome compared with controls. This could be a result of hypothalamic damage causing obesity and GH deficiency. Further studies exploring predictors of the metabolic syndrome after craniopharyngioma surgery are required.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14715831     DOI: 10.1210/jc.2003-030442

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  47 in total

1.  Hyperinsulinemia may promote growth without GH in children after resection of suprasellar brain tumors.

Authors:  Hideyuki Iwayama; Takashi Kamijo; Norishi Ueda
Journal:  Endocrine       Date:  2011-06-03       Impact factor: 3.633

Review 2.  Childhood craniopharyngioma--current concepts in diagnosis, therapy and follow-up.

Authors:  Hermann L Müller
Journal:  Nat Rev Endocrinol       Date:  2010-09-28       Impact factor: 43.330

3.  Survival, hypothalamic obesity, and neuropsychological/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes.

Authors:  Anthe S Sterkenburg; Anika Hoffmann; Ursel Gebhardt; Monika Warmuth-Metz; Anna M M Daubenbüchel; Hermann L Müller
Journal:  Neuro Oncol       Date:  2015-04-02       Impact factor: 12.300

4.  Pediatric obesity. An introduction.

Authors:  Jack A Yanovski
Journal:  Appetite       Date:  2015-03-30       Impact factor: 3.868

Review 5.  Pediatric Craniopharyngiomas: A Primer for the Skull Base Surgeon.

Authors:  Christopher Salvatore Graffeo; Avital Perry; Michael J Link; David J Daniels
Journal:  J Neurol Surg B Skull Base       Date:  2018-01-19

Review 6.  Pediatric obesity: etiology and treatment.

Authors:  Melissa K Crocker; Jack A Yanovski
Journal:  Pediatr Clin North Am       Date:  2011-10       Impact factor: 3.278

7.  Hypothalamic obesity syndrome: rare presentation of CNS+ B-cell lymphoblastic lymphoma.

Authors:  Troy C Quigg; Nadine G Haddad; Jeffrey C Buchsbaum; Chie-Schin Shih
Journal:  Pediatr Blood Cancer       Date:  2011-12-27       Impact factor: 3.167

Review 8.  Risk-adapted, long-term management in childhood-onset craniopharyngioma.

Authors:  Hermann L Müller
Journal:  Pituitary       Date:  2017-04       Impact factor: 4.107

Review 9.  Pediatric obesity: etiology and treatment.

Authors:  Melissa K Crocker; Jack A Yanovski
Journal:  Endocrinol Metab Clin North Am       Date:  2009-09       Impact factor: 4.741

10.  Childhood craniopharyngioma: greater hypothalamic involvement before surgery is associated with higher homeostasis model insulin resistance index.

Authors:  Christine Trivin; Kanetee Busiah; Nizar Mahlaoui; Christophe Recasens; Jean-Claude Souberbielle; Michel Zerah; Christian Sainte-Rose; Raja Brauner
Journal:  BMC Pediatr       Date:  2009-04-02       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.